Everpar Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$787K Buy
1,569
+183
+13% +$87.8K 0.22% 94
2026
Q1
$681K Buy
1,386
+113
+9% +$61.3K 0.23% 87
2025
Q4
$738K Buy
1,273
+282
+28% +$159K 0.27% 73
2025
Q3
$481K Buy
991
+217
+28% +$101K 0.19% 125
2025
Q2
$314K Buy
774
+12
+2% +$5.02K 0.14% 196
2025
Q1
$379K Buy
762
+2
+0.3% +$1.08K 0.2% 137
2024
Q4
$395K Sell
760
-137
-15% -$75.3K 0.2% 141
2024
Q3
$555K Sell
897
-156
-15% -$92.3K 0.29% 98
2024
Q2
$582K Buy
1,053
+244
+30% +$140K 0.29% 101
2024
Q1
$470K Sell
809
-131
-14% -$73.5K 0.29% 116
2023
Q4
$499K Buy
+940
New +$455K 0.23% 154

Other funds holding TMO

Everpar Advisors's TMO Position: Q2 2026 in Review

Everpar Advisors increased its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, buying an estimated $87.8K and bringing the position to 1,569 shares worth $787K. The position accounts for 0.22% of the portfolio, ranked #94.

Everpar Advisors first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Everpar Advisors held 1,569 shares of Thermo Fisher Scientific worth $787K as of Q2 2026.
  • Everpar Advisors bought 183 Thermo Fisher Scientific shares in Q2 2026, an estimated $87.8K.
  • Thermo Fisher Scientific made up 0.22% of Everpar Advisors's portfolio in Q2 2026, its #94 holding.
  • Everpar Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • 429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.